OmniAb OABI
NASDAQ OABI
$4.87 -0.12 (-2.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

OmniAb (OABI) Non Operating Investment Income (2022)

Updated

OmniAb (OABI) posted Non Operating Investment Income of $1.09 million for Q3 2022, up 267.1% from the prior quarter.

Analysis

OmniAb (OABI) Non Operating Investment Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 OmniAb 708.05 Mn 493.46 Mn 12.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 1.09 Mn
Jun 30, 2022 297,047.00
Mar 31, 2022 51,285.00
API Access

OmniAb Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=OABI&period=max&api_key=YOUR_API_KEY